Tuesday, August 11, 2026

NASA and Global Scientists Monitor Asteroid 2024 YR4 Amid Potential Earth Impact Risk

An asteroid, 2024 YR4, poses a 2.2% collision risk with Earth in 2032, prompting NASA and ESA to develop defense strategies.

Korean Pharma in Trump’s Crosshairs: A 25% Tariff Threat—and Why U.S. Drug Prices Could Be the Real Risk

The U.S. plans a 25% tariff on Korean pharmaceuticals, raising concerns for both industries amid potential impacts on U.S. consumers.

Korean Opposition Party’s U.S. Visit: Key Diplomatic Strategies for 2026

The People Power Party's delegation, led by Jang Dong-hyuk, is meeting U.S. officials to discuss Middle East issues and U.S.-South Korea relations.

Tag: RNA therapeutics

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

ST Pharm Targets Next-Generation RNA Therapies, Positions Itself as Key CDMO Partner at BIO USA

The RNA therapeutics market is evolving, with ST Pharm aiming to lead in precision manufacturing and targeted delivery for next-gen therapies.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.